BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11089230)

  • 1. Quinolone interactions with DNA and DNA gyrase.
    Shen LL
    Methods Mol Biol; 2001; 95():171-84. PubMed ID: 11089230
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasmid DNA supercoiling by DNA gyrase.
    Sayer PJ; Goble ML; Oram M; Fisher LM
    Methods Mol Biol; 2001; 95():25-33. PubMed ID: 11089216
    [No Abstract]   [Full Text] [Related]  

  • 3. Bactericidal assays for fluoroquinolones.
    Gootz TD
    Methods Mol Biol; 2001; 95():185-94. PubMed ID: 11089231
    [No Abstract]   [Full Text] [Related]  

  • 4. gyrB-225, a mutation of DNA gyrase that compensates for topoisomerase I deficiency: investigation of its low activity and quinolone hypersensitivity.
    Heddle JG; Lu T; Zhao X; Drlica K; Maxwell A
    J Mol Biol; 2001 Jun; 309(5):1219-31. PubMed ID: 11399091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of active site binding of 4-quinolones and novel flavone gyrase inhibitors to DNA gyrase.
    Hilliard JJ; Krause HM; Bernstein JI; Fernandez JA; Nguyen V; Ohemeng KA; Barrett JF
    Adv Exp Med Biol; 1995; 390():59-69. PubMed ID: 8718602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topoisomerase IV, not gyrase, decatenates products of site-specific recombination in Escherichia coli.
    Zechiedrich EL; Khodursky AB; Cozzarelli NR
    Genes Dev; 1997 Oct; 11(19):2580-92. PubMed ID: 9334322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of topoisomerases in maintaining steady-state DNA supercoiling in Escherichia coli.
    Zechiedrich EL; Khodursky AB; Bachellier S; Schneider R; Chen D; Lilley DM; Cozzarelli NR
    J Biol Chem; 2000 Mar; 275(11):8103-13. PubMed ID: 10713132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topoisomerase II-catalyzed relaxation and catenation of plasmid DNA.
    Fortune JM; Osheroff N
    Methods Mol Biol; 2001; 95():275-81. PubMed ID: 11089239
    [No Abstract]   [Full Text] [Related]  

  • 9. A single point mutation in the DNA gyrase A protein greatly reduces binding of fluoroquinolones to the gyrase-DNA complex.
    Willmott CJ; Maxwell A
    Antimicrob Agents Chemother; 1993 Jan; 37(1):126-7. PubMed ID: 8381633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of differential activities of ofloxacin enantiomers.
    Morrissey I; Hoshino K; Sato K; Yoshida A; Hayakawa I; Bures MG; Shen LL
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1775-84. PubMed ID: 8843280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Norfloxacin-induced DNA cleavage occurs at the dif resolvase locus in Escherichia coli and is the result of interaction with topoisomerase IV.
    Hojgaard A; Szerlong H; Tabor C; Kuempel P
    Mol Microbiol; 1999 Sep; 33(5):1027-36. PubMed ID: 10476036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanism of inhibition of topoisomerase IV by quinolone antibacterials.
    Khodursky AB; Cozzarelli NR
    J Biol Chem; 1998 Oct; 273(42):27668-77. PubMed ID: 9765303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topoisomerase II-mediated cleavage of plasmid DNA.
    Burden DA; Froelich-Ammon SJ; Osheroff N
    Methods Mol Biol; 2001; 95():283-9. PubMed ID: 11089240
    [No Abstract]   [Full Text] [Related]  

  • 14. Selective inhibition of DNA gyrase in vitro by a GC specific eight-ring hairpin polyamide at nanomolar concentration.
    Simon H; Kittler L; Baird E; Dervan P; Zimmer C
    FEBS Lett; 2000 Apr; 471(2-3):173-6. PubMed ID: 10767417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates.
    Tavío MM; Vila J; Ruiz J; Ruiz J; Martín-Sánchez AM; Jiménez de Anta MT
    J Antimicrob Chemother; 1999 Dec; 44(6):735-42. PubMed ID: 10590273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High pressure modulation of Escherichia coli DNA gyrase activity.
    Chilukuri LN; Fortes PA; Bartlett DH
    Biochem Biophys Res Commun; 1997 Oct; 239(2):552-6. PubMed ID: 9344868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased sensitivity to quinolone antibacterials can be engineered in human topoisomerase IIalpha by selective mutagenesis.
    Hammonds TR; Foster SR; Maxwell A
    J Mol Biol; 2000 Jul; 300(3):481-91. PubMed ID: 10884345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of inhibition of DNA gyrase by cyclothialidine, a novel DNA gyrase inhibitor.
    Nakada N; Gmünder H; Hirata T; Arisawa M
    Antimicrob Agents Chemother; 1994 Sep; 38(9):1966-73. PubMed ID: 7811004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA gyrase and DNA supercoiling.
    Gellert M; Mizuuchi K; O'Dea MH; Ohmori H; Tomizawa J
    Cold Spring Harb Symp Quant Biol; 1979; 43 Pt 1():35-40. PubMed ID: 225107
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of DNA topoisomerases involved in immediate and transient DNA relaxation induced by heat shock in Escherichia coli.
    Ogata Y; Mizushima T; Kataoka K; Miki T; Sekimizu K
    Mol Gen Genet; 1994 Sep; 244(5):451-5. PubMed ID: 8078472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.